(SYNA) Synaptics - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US87157D1090
Stock: Touch, Display, Biometrics, Wireless, Processor
Total Rating 53
Risk 98
Buy Signal 0.52
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 45.4% |
| Relative Tail Risk | -11.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.52 |
| Alpha | -10.53 |
| Character TTM | |
|---|---|
| Beta | 2.077 |
| Beta Downside | 2.073 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.78% |
| CAGR/Max DD | -0.16 |
Description: SYNA Synaptics January 13, 2026
Synaptics (NASDAQ:SYNA) designs and sells a broad portfolio of semiconductor solutions-including touch, display, biometric, voice, audio, wireless, and AI/ML-enabled processors-targeting mobile, PC, smart-home, industrial, and automotive markets. Its offerings extend to connectivity modules (Wi-Fi, Bluetooth, Zigbee, Thread, Matter, GPS/GNSS, UWB), display driver ICs, and development kits that integrate software frameworks and AI toolchains. The company distributes products through direct sales, OEM partners, distributors, and value-added resellers, and has been operating since 1986 from its San Jose headquarters.
Key recent metrics: FY2023 revenue reached approximately $1.4 billion, with a 12% year-over-year increase driven largely by automotive and IoT demand; gross margin expanded to 38% as higher-margin AI/ML solutions gained traction. Sector-wide, the semiconductor industry is benefitting from a secular shift toward edge-AI and connected devices, while supply-chain tightening and rising component costs remain material headwinds that could pressure earnings.
For a deeper, data-driven assessment of SYNA’s valuation and risk profile, you may find ValueRay’s analyst framework worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -45.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.21 > 1.0 |
| NWC/Revenue: 43.91% < 20% (prev 90.46%; Δ -46.55% < -1%) |
| CFO/TA 0.07 > 3% & CFO 183.6m > Net Income -45.3m |
| Net Debt (501.0m) to EBITDA (82.6m): 6.07 < 3 |
| Current Ratio: 2.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.3m) vs 12m ago -1.50% < -2% |
| Gross Margin: 43.65% > 18% (prev 0.46%; Δ 4318 % > 0.5%) |
| Asset Turnover: 41.32% > 50% (prev 35.09%; Δ 6.23% > 0%) |
| Interest Coverage Ratio: -9.52 > 6 (EBITDA TTM 82.6m / Interest Expense TTM 7.50m) |
Altman Z'' 3.58
| A: 0.19 (Total Current Assets 749.0m - Total Current Liabilities 262.0m) / Total Assets 2.58b |
| B: 0.45 (Retained Earnings 1.17b / Total Assets 2.58b) |
| C: -0.03 (EBIT TTM -71.4m / Avg Total Assets 2.68b) |
| D: 0.99 (Book Value of Equity 1.17b / Total Liabilities 1.18b) |
| Altman-Z'' Score: 3.58 = A |
Beneish M -3.05
| DSRI: 0.78 (Receivables 119.5m/135.8m, Revenue 1.11b/979.4m) |
| GMI: 1.06 (GM 43.65% / 46.31%) |
| AQI: 1.18 (AQ_t 0.66 / AQ_t-1 0.56) |
| SGI: 1.13 (Revenue 1.11b / 979.4m) |
| TATA: -0.09 (NI -45.3m - CFO 183.6m) / TA 2.58b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of SYNA shares?
As of February 07, 2026, the stock is trading at USD 89.23 with a total of 1,799,243 shares traded.
Over the past week, the price has changed by +8.14%, over one month by +2.69%, over three months by +30.05% and over the past year by +19.26%.
Over the past week, the price has changed by +8.14%, over one month by +2.69%, over three months by +30.05% and over the past year by +19.26%.
Is SYNA a buy, sell or hold?
Synaptics has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy SYNA.
- StrongBuy: 4
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SYNA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 91.8 | 2.9% |
| Analysts Target Price | 91.8 | 2.9% |
| ValueRay Target Price | 93.7 | 5% |
SYNA Fundamental Data Overview February 01, 2026
P/E Forward = 18.9394
P/S = 2.9051
P/B = 2.2969
P/EG = 0.4818
Revenue TTM = 1.11b USD
EBIT TTM = -71.4m USD
EBITDA TTM = 82.6m USD
Long Term Debt = 835.4m USD (from longTermDebt, last quarter)
Short Term Debt = 11.3m USD (from shortTermDebt, last quarter)
Debt = 880.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 501.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.64b USD (3.22b + Debt 880.2m - CCE 459.9m)
Interest Coverage Ratio = -9.52 (Ebit TTM -71.4m / Interest Expense TTM 7.50m)
EV/FCF = 25.17x (Enterprise Value 3.64b / FCF TTM 144.7m)
FCF Yield = 3.97% (FCF TTM 144.7m / Enterprise Value 3.64b)
FCF Margin = 13.05% (FCF TTM 144.7m / Revenue TTM 1.11b)
Net Margin = -4.08% (Net Income TTM -45.3m / Revenue TTM 1.11b)
Gross Margin = 43.65% ((Revenue TTM 1.11b - Cost of Revenue TTM 625.0m) / Revenue TTM)
Gross Margin QoQ = 42.60% (prev 42.96%)
Tobins Q-Ratio = 1.41 (Enterprise Value 3.64b / Total Assets 2.58b)
Interest Expense / Debt = 0.06% (Interest Expense 500.0k / Debt 880.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = -56.4m (EBIT -71.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.86 (Total Current Assets 749.0m / Total Current Liabilities 262.0m)
Debt / Equity = 0.63 (Debt 880.2m / totalStockholderEquity, last quarter 1.40b)
Debt / EBITDA = 6.07 (Net Debt 501.0m / EBITDA 82.6m)
Debt / FCF = 3.46 (Net Debt 501.0m / FCF TTM 144.7m)
Total Stockholder Equity = 1.39b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.69% (Net Income -45.3m / Total Assets 2.58b)
RoE = -3.26% (Net Income TTM -45.3m / Total Stockholder Equity 1.39b)
RoCE = -3.21% (EBIT -71.4m / Capital Employed (Equity 1.39b + L.T.Debt 835.4m))
RoIC = -2.54% (negative operating profit) (NOPAT -56.4m / Invested Capital 2.22b)
WACC = 10.67% (E(3.22b)/V(4.10b) * Re(13.57%) + D(880.2m)/V(4.10b) * Rd(0.06%) * (1-Tc(0.21)))
Discount Rate = 13.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.13%
[DCF Debug] Terminal Value 59.25% ; FCFF base≈102.5m ; Y1≈67.3m ; Y5≈30.7m
Fair Price DCF = N/A (negative equity: EV 413.3m - Net Debt 501.0m = -87.7m; debt exceeds intrinsic value)
EPS Correlation: -67.13 | EPS CAGR: -25.33% | SUE: 0.63 | # QB: 0
Revenue Correlation: -69.54 | Revenue CAGR: -9.23% | SUE: 1.83 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.98 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=13
EPS current Year (2026-06-30): EPS=4.35 | Chg30d=+0.003 | Revisions Net=+6 | Growth EPS=+20.1% | Growth Revenue=+10.1%
EPS next Year (2027-06-30): EPS=5.25 | Chg30d=-0.073 | Revisions Net=+0 | Growth EPS=+20.8% | Growth Revenue=+10.7%
P/S = 2.9051
P/B = 2.2969
P/EG = 0.4818
Revenue TTM = 1.11b USD
EBIT TTM = -71.4m USD
EBITDA TTM = 82.6m USD
Long Term Debt = 835.4m USD (from longTermDebt, last quarter)
Short Term Debt = 11.3m USD (from shortTermDebt, last quarter)
Debt = 880.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 501.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.64b USD (3.22b + Debt 880.2m - CCE 459.9m)
Interest Coverage Ratio = -9.52 (Ebit TTM -71.4m / Interest Expense TTM 7.50m)
EV/FCF = 25.17x (Enterprise Value 3.64b / FCF TTM 144.7m)
FCF Yield = 3.97% (FCF TTM 144.7m / Enterprise Value 3.64b)
FCF Margin = 13.05% (FCF TTM 144.7m / Revenue TTM 1.11b)
Net Margin = -4.08% (Net Income TTM -45.3m / Revenue TTM 1.11b)
Gross Margin = 43.65% ((Revenue TTM 1.11b - Cost of Revenue TTM 625.0m) / Revenue TTM)
Gross Margin QoQ = 42.60% (prev 42.96%)
Tobins Q-Ratio = 1.41 (Enterprise Value 3.64b / Total Assets 2.58b)
Interest Expense / Debt = 0.06% (Interest Expense 500.0k / Debt 880.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = -56.4m (EBIT -71.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.86 (Total Current Assets 749.0m / Total Current Liabilities 262.0m)
Debt / Equity = 0.63 (Debt 880.2m / totalStockholderEquity, last quarter 1.40b)
Debt / EBITDA = 6.07 (Net Debt 501.0m / EBITDA 82.6m)
Debt / FCF = 3.46 (Net Debt 501.0m / FCF TTM 144.7m)
Total Stockholder Equity = 1.39b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.69% (Net Income -45.3m / Total Assets 2.58b)
RoE = -3.26% (Net Income TTM -45.3m / Total Stockholder Equity 1.39b)
RoCE = -3.21% (EBIT -71.4m / Capital Employed (Equity 1.39b + L.T.Debt 835.4m))
RoIC = -2.54% (negative operating profit) (NOPAT -56.4m / Invested Capital 2.22b)
WACC = 10.67% (E(3.22b)/V(4.10b) * Re(13.57%) + D(880.2m)/V(4.10b) * Rd(0.06%) * (1-Tc(0.21)))
Discount Rate = 13.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.13%
[DCF Debug] Terminal Value 59.25% ; FCFF base≈102.5m ; Y1≈67.3m ; Y5≈30.7m
Fair Price DCF = N/A (negative equity: EV 413.3m - Net Debt 501.0m = -87.7m; debt exceeds intrinsic value)
EPS Correlation: -67.13 | EPS CAGR: -25.33% | SUE: 0.63 | # QB: 0
Revenue Correlation: -69.54 | Revenue CAGR: -9.23% | SUE: 1.83 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.98 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=13
EPS current Year (2026-06-30): EPS=4.35 | Chg30d=+0.003 | Revisions Net=+6 | Growth EPS=+20.1% | Growth Revenue=+10.1%
EPS next Year (2027-06-30): EPS=5.25 | Chg30d=-0.073 | Revisions Net=+0 | Growth EPS=+20.8% | Growth Revenue=+10.7%